Ontario Study Flags Critical Gap in Syphilis Screening

A new study published out of Ontario has surfaced a troubling blind spot in Canadian prenatal care: roughly one in five pregnant people in the province were not adequately screened for syphilis, a preventable infection that can be catastrophic when transmitted from mother to baby.

The research underscores what public health officials have long warned—that despite the disease's rarity in wealthy nations, gaps in screening infrastructure persist. Syphilis in pregnancy can cause stillbirth, neonatal death, and severe congenital complications. It's treatable with antibiotics, making the screening failure a preventable tragedy.

Why it matters now: syphilis rates have been climbing across Canada and North America for nearly a decade. The trend follows decades of relative dormancy, meaning screening protocols that worked in the 2000s may not be embedded deeply enough in modern care pathways. Providers rotating through systems, shifting lab workflows, and inconsistent patient education have all created cracks where a simple test should be routine.

The study's findings are raising questions about whether prenatal screening protocols need overhaul—not just in Ontario, but across the country. Public health agencies will likely respond, but the immediate takeaway for prospective parents is clear: ask your care provider directly whether syphilis screening was included in your first trimester bloodwork. It's a conversation that shouldn't require advocacy, but evidence suggests it sometimes does.